Indian clinical practice consensus guidelines for the management of oral cavity cancer: Update 2022
The treatment of oral cavity cancer primarily depends on the location, tumor size, and feasibility of organ preservation in patients with negative margins. A liquid biopsy is a minimally invasive approach for detecting blood-based signatures such as circulating tumor cells (CTCs) and circulatory tum...
Saved in:
| Published in | Cancer research, statistics, and treatment (Online) Vol. 7; no. Suppl 1; pp. S6 - S11 |
|---|---|
| Main Authors | , , , , , , , , , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
India
Wolters Kluwer - Medknow
01.01.2024
|
| Edition | 2 |
| Subjects | |
| Online Access | Get full text |
| ISSN | 2590-3233 2590-3225 |
| DOI | 10.4103/crst.crst_119_23 |
Cover
| Abstract | The treatment of oral cavity cancer primarily depends on the location, tumor size, and feasibility of organ preservation in patients with negative margins. A liquid biopsy is a minimally invasive approach for detecting blood-based signatures such as circulating tumor cells (CTCs) and circulatory tumor DNA (ctDNA). To assess the presence of occult metastatic disease, sentinel lymph node biopsy (SLNB) is recommended in early-stage oral cavity cancer (OCC). In India, surgery is the preferred choice of treatment for oral cancers. Selected patients, who are medically inoperable or refuse surgery, should be given definitive radiotherapy (RT) as an alternative to surgery. Concurrent chemoradiation (CCRT) may be considered an alternative option to definitive RT in patients with unresectable oral cancer. |
|---|---|
| AbstractList | The treatment of oral cavity cancer primarily depends on the location, tumor size, and feasibility of organ preservation in patients with negative margins. A liquid biopsy is a minimally invasive approach for detecting blood-based signatures such as circulating tumor cells (CTCs) and circulatory tumor DNA (ctDNA). To assess the presence of occult metastatic disease, sentinel lymph node biopsy (SLNB) is recommended in early-stage oral cavity cancer (OCC). In India, surgery is the preferred choice of treatment for oral cancers. Selected patients, who are medically inoperable or refuse surgery, should be given definitive radiotherapy (RT) as an alternative to surgery. Concurrent chemoradiation (CCRT) may be considered an alternative option to definitive RT in patients with unresectable oral cancer. |
| Author | Goyal, Sumit Noronha, Vanita John, Subashini Ramachandra, Prakash Birur, Praveen Syiemlieh, Judita Chaturvedi, Pankaj Mahajan, Abhishek Roshan, Vikas Babu, K Govind Patil, Vijay M Anand, Anil K. Gairola, Munish Prabhash, Kumar Singhal, Manish Kaushal, Ashish Rath, G.K. Kuriakose, Moni Nayyar, Rohit Rao, Vishal |
| Author_xml | – sequence: 1 givenname: Pankaj surname: Chaturvedi fullname: Chaturvedi, Pankaj – sequence: 2 givenname: Kumar surname: Prabhash fullname: Prabhash, Kumar – sequence: 3 givenname: K Govind surname: Babu fullname: Babu, K Govind – sequence: 4 givenname: Moni surname: Kuriakose fullname: Kuriakose, Moni – sequence: 5 givenname: Praveen surname: Birur fullname: Birur, Praveen – sequence: 6 givenname: Anil K. surname: Anand fullname: Anand, Anil K. – sequence: 7 givenname: Ashish surname: Kaushal fullname: Kaushal, Ashish – sequence: 8 givenname: Abhishek surname: Mahajan fullname: Mahajan, Abhishek – sequence: 9 givenname: Judita surname: Syiemlieh fullname: Syiemlieh, Judita – sequence: 10 givenname: Manish surname: Singhal fullname: Singhal, Manish – sequence: 11 givenname: Munish surname: Gairola fullname: Gairola, Munish – sequence: 12 givenname: Prakash surname: Ramachandra fullname: Ramachandra, Prakash – sequence: 13 givenname: Sumit surname: Goyal fullname: Goyal, Sumit – sequence: 14 givenname: Subashini surname: John fullname: John, Subashini – sequence: 15 givenname: Rohit surname: Nayyar fullname: Nayyar, Rohit – sequence: 16 givenname: Vijay M surname: Patil fullname: Patil, Vijay M – sequence: 17 givenname: Vishal surname: Rao fullname: Rao, Vishal – sequence: 18 givenname: Vanita surname: Noronha fullname: Noronha, Vanita – sequence: 19 givenname: Vikas surname: Roshan fullname: Roshan, Vikas – sequence: 20 givenname: G.K. surname: Rath fullname: Rath, G.K. |
| BookMark | eNp9kEtLAzEUhYNUsNbuXeYPTJ285uFOitpCwYV2HdLMTQ2dSUqSWvrvnVoVEXRzz4XDdxbfJRo47wCha5JPOMnZjQ4xTY5HElJLys7QkIo6zxilYvD9M3aBxjHaVc55yahgYoj03DVWOaxb66xWLd4GpZPVgLV3EVzcRbze2Qb6HiI2PuD0CrhTTq2hA5ewN9iHHtTqzaZDH05DuMXLbaMSYJpTeoXOjWojjD9zhJYP9y_TWbZ4epxP7xaZJrVos4IUplKl4itRFZzTShBuSFWChpyXwrCSlAZMYwpGa2G44EoQKBqijSkNpWyEitOuDj7GAEZqm1Sy3qWgbCtJLo-25IeoH7Z6MP8FboPtVDj8h8xOyN63CULctLs9BNlBs3F-_ycnnwt5Mi6_jLN3E4uN3g |
| CitedBy_id | crossref_primary_10_1016_j_ejca_2024_113560 crossref_primary_10_4103_crst_crst_118_23 |
| Cites_doi | 10.2147/CMAR.S283204 10.1002/lary.27627 10.1016/j.radonc.2021.01.013 10.1056/NEJMoa1506007 10.1200/JCO.2022.40.16_suppl.6004 10.1200/JCO.2017.74.9457 10.1001/archoto.2010.223 10.1186/s13014-017-0910-0 10.3390/biomedicines9101478 10.3390/cancers14122968 10.1002/cam4.4726 10.1056/NEJMoa032646 10.3390/ijms19061704 10.4103/jomfp.JOMFP_36_19 10.1002/lary.24840 10.1016/j.ijrobp.2012.05.008 10.1371/journal.pone.0170322 10.1007/s12663-021-01677-z 10.1016/j.oooo.2022.02.018 10.1200/JCO.21.01293 10.1371/journal.pone.0132901 10.3390/biomedicines9111548 10.1002/hed.20279 10.1016/j.oraloncology.2015.12.002 10.1200/JCO.22.00980 10.4103/0973-1482.188426 10.3390/cancers13081874 |
| ContentType | Journal Article |
| Copyright | Copyright: © 2024 Cancer Research, Statistics, and Treatment |
| Copyright_xml | – notice: Copyright: © 2024 Cancer Research, Statistics, and Treatment |
| DBID | AAYXX CITATION |
| DOI | 10.4103/crst.crst_119_23 |
| DatabaseName | CrossRef |
| DatabaseTitle | CrossRef |
| DatabaseTitleList | CrossRef |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 2590-3225 |
| Edition | 2 |
| EndPage | S11 |
| ExternalDocumentID | 10_4103_crst_crst_119_23 CRSAT-7-S6 |
| GroupedDBID | ALMA_UNASSIGNED_HOLDINGS GROUPED_DOAJ OK1 OVD RMW TEORI W3E AAYXX ADJBI CITATION |
| ID | FETCH-LOGICAL-c195l-616f8a7a4b5864428514f187ece0475f3717fefdf63295f454a51e6d1cff7f223 |
| IEDL.DBID | W3E |
| ISSN | 2590-3233 |
| IngestDate | Thu Apr 24 22:56:00 EDT 2025 Tue Jul 01 03:54:05 EDT 2025 Wed May 28 23:14:07 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | Suppl 1 |
| Keywords | Indian guidelines oral recommendations Chemoradiation |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c195l-616f8a7a4b5864428514f187ece0475f3717fefdf63295f454a51e6d1cff7f223 |
| OpenAccessLink | https://doi.org/10.4103/crst.crst_119_23 |
| ParticipantIDs | crossref_citationtrail_10_4103_crst_crst_119_23 crossref_primary_10_4103_crst_crst_119_23 wolterskluwer_medknow_10_4103_crst_crst_119_23_S6_Indian_clinical |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 20240100 2024-01-00 |
| PublicationDateYYYYMMDD | 2024-01-01 |
| PublicationDate_xml | – month: 01 year: 2024 text: 20240100 |
| PublicationDecade | 2020 |
| PublicationPlace | India |
| PublicationPlace_xml | – name: India |
| PublicationTitle | Cancer research, statistics, and treatment (Online) |
| PublicationYear | 2024 |
| Publisher | Wolters Kluwer - Medknow |
| Publisher_xml | – name: Wolters Kluwer - Medknow |
| References | Pérez-Ruiz (R23-20240828) 2021; 9 Mazurek (R21-20240828) 2016; 54 Bernier (R10-20240828) 2005; 27 D'Cruz (R4-20240828) 2015; 373 Madera (R16-20240828) 2021; 13 Lousada-Fernandez (R18-20240828) 2018; 19 Huang (R6-20240828) 2015; 125 Kogo (R26-20240828) 2022; 11 Cooper (R8-20240828) 2004; 350 Sharma (R17-20240828) 2022; 16 Babji (R25-20240828) 2019; 23 Massey (R5-20240828) 2019; 129 Kalyanam (R2-20240828) 2018; 14 Cooper (R9-20240828) 2012; 84 Lacas (R15-20240828) 2021; 156 Inhestern (R24-20240828) 2015; 10 Hudečková (R27-20240828) 2021; 9 Kumar (R3-20240828) 2022; 21 Kiyota (R12-20240828) 2022; 40 Patil (R13-20240828) 2023; 41 Aulakh (R28-20240828) 2022; 14 Noronha (R11-20240828) 2018; 36 Jatana (R22-20240828) 2010; 136 Kong (R20-20240828) 2021; 13 Liu (R7-20240828) 2017; 12 Fan (R14-20240828) 2017; 12 Qayyumi (R19-20240828) 2022; 134 R1-20240828 |
| References_xml | – volume: 13 start-page: 6705 year: 2021 ident: R16-20240828 article-title: Therapeutic options in unresectable oral squamous cell carcinoma: A systematic review publication-title: Cancer Manag Res doi: 10.2147/CMAR.S283204 – volume: 129 start-page: E284 year: 2019 ident: R5-20240828 article-title: Management of N0 neck in early oral squamous cell carcinoma: A systematic review and meta-analysis publication-title: Laryngoscope doi: 10.1002/lary.27627 – volume: 156 start-page: 281 year: 2021 ident: R15-20240828 article-title: Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC group publication-title: Radiother Oncol doi: 10.1016/j.radonc.2021.01.013 – volume: 373 start-page: 521 year: 2015 ident: R4-20240828 article-title: Elective versus therapeutic neck dissection in node-negative oral cancer publication-title: N Engl J Med doi: 10.1056/NEJMoa1506007 – volume: 16 start-page: 6004. year: 2022 ident: R17-20240828 article-title: An open label, noninferiority phase III RCT of weekly versus three weekly cisplatin and radical radiotherapy in locally advanced head and neck squamous cell carcinoma (ConCERT trial) publication-title: J Clin Oncol doi: 10.1200/JCO.2022.40.16_suppl.6004 – volume: 36 start-page: 1064 year: 2018 ident: R11-20240828 article-title: Once-a-week versus once-every-3-weeks cisplatin chemoradiation for locally advanced head and neck cancer: A phase iii randomized noninferiority trial publication-title: J Clin Oncol doi: 10.1200/JCO.2017.74.9457 – volume: 136 start-page: 1274 year: 2010 ident: R22-20240828 article-title: Significance of circulating tumor cells in patients with squamous cell carcinoma of the head and neck: Initial results publication-title: Arch Otolaryngol Head Neck Surg doi: 10.1001/archoto.2010.223 – volume: 12 start-page: 184. year: 2017 ident: R14-20240828 article-title: Postoperative radiotherapy with or without concurrent chemotherapy for oral squamous cell carcinoma in patients with three or more minor risk factors: A propensity score matching analysis publication-title: Radiat Oncol doi: 10.1186/s13014-017-0910-0 – volume: 9 start-page: 1478. year: 2021 ident: R23-20240828 article-title: Liquid biopsy as a tool for the characterisation and early detection of the field cancerization effect in patients with oral cavity carcinoma publication-title: Biomedicines doi: 10.3390/biomedicines9101478 – volume: 14 start-page: 2968. year: 2022 ident: R28-20240828 article-title: The promise of circulating Tumor DNA in head and neck Cancer publication-title: Cancers (Basel) doi: 10.3390/cancers14122968 – volume: 11 start-page: 3960 year: 2022 ident: R26-20240828 article-title: Individualized circulating tumor DNA monitoring in head and neck squamous cell carcinoma publication-title: Cancer Med doi: 10.1002/cam4.4726 – volume: 350 start-page: 1937 year: 2004 ident: R8-20240828 article-title: Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck publication-title: N Engl J Med doi: 10.1056/NEJMoa032646 – volume: 19 start-page: 1704. year: 2018 ident: R18-20240828 article-title: Liquid biopsy in oral cancer publication-title: Int J Mol Sci doi: 10.3390/ijms19061704 – volume: 23 start-page: 273 year: 2019 ident: R25-20240828 article-title: Cell-free tumor DNA: Emerging reality in oral squamous cell carcinoma publication-title: J Oral Maxillofac Pathol doi: 10.4103/jomfp.JOMFP_36_19 – volume: 125 start-page: 128 year: 2015 ident: R6-20240828 article-title: The role of elective neck dissection in early stage buccal cancer publication-title: Laryngoscope doi: 10.1002/lary.24840 – volume: 84 start-page: 1198 year: 2012 ident: R9-20240828 article-title: Long-term follow-up of the RTOG 9501/intergroup phase III trial: Postoperative concurrent radiation therapy and chemotherapy in high-risk squamous cell carcinoma of the head and neck publication-title: Int J Radiat Oncol Biol Phys doi: 10.1016/j.ijrobp.2012.05.008 – volume: 12 start-page: e0170322. year: 2017 ident: R7-20240828 article-title: Diagnostic efficacy of sentinel lymph node biopsy in early oral squamous cell carcinoma: A meta-analysis of 66 studies publication-title: PLoS One doi: 10.1371/journal.pone.0170322 – volume: 21 start-page: 340 year: 2022 ident: R3-20240828 article-title: Elective neck dissection versus therapeutic neck dissection in clinically node-negative early stage oral cancer: A meta-analysis of randomized controlled trials publication-title: J Maxillofac Oral Surg doi: 10.1007/s12663-021-01677-z – volume: 134 start-page: 73 year: 2022 ident: R19-20240828 article-title: Circulating tumor cells as a predictor for poor prognostic factors and overall survival in treatment naïve oral squamous cell carcinoma patients publication-title: Oral Surg Oral Med Oral Pathol Oral Radiol doi: 10.1016/j.oooo.2022.02.018 – volume: 40 start-page: 1980 year: 2022 ident: R12-20240828 article-title: Weekly cisplatin plus radiation for postoperative head and neck cancer (JCOG1008): A multicenter, noninferiority, phase II/III randomized controlled trial publication-title: J Clin Oncol doi: 10.1200/JCO.21.01293 – volume: 10 start-page: e0132901. year: 2015 ident: R24-20240828 article-title: Prognostic role of circulating tumor cells during induction chemotherapy followed by curative surgery combined with postoperative radiotherapy in patients with locally advanced oral and oropharyngeal squamous cell cancer publication-title: PLoS One doi: 10.1371/journal.pone.0132901 – volume: 9 start-page: 1548. year: 2021 ident: R27-20240828 article-title: Gene mutations in circulating tumour DNA as a diagnostic and prognostic marker in head and neck cancer-A systematic review publication-title: Biomedicines doi: 10.3390/biomedicines9111548 – volume: 27 start-page: 843 year: 2005 ident: R10-20240828 article-title: Defining risk levels in locally advanced head and neck cancers: A comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501) publication-title: Head Neck doi: 10.1002/hed.20279 – volume: 54 start-page: 36 year: 2016 ident: R21-20240828 article-title: Assessment of the total cfDNA and HPV16/18 detection in plasma samples of head and neck squamous cell carcinoma patients publication-title: Oral Oncol doi: 10.1016/j.oraloncology.2015.12.002 – ident: R1-20240828 article-title: Guideline version 2.2019. Head and neck cancers – volume: 41 start-page: 2350 year: 2023 ident: R13-20240828 article-title: Results of phase III randomized trial for use of docetaxel as a radiosensitizer in patients with head and neck cancer, unsuitable for cisplatin-based chemoradiation publication-title: J Clin Oncol doi: 10.1200/JCO.22.00980 – volume: 14 start-page: 1099 year: 2018 ident: R2-20240828 article-title: Auditory function and quality of life in patients receiving cisplatin chemotherapy in head and neck cancer: A case series follow-up study publication-title: J Cancer Res Ther doi: 10.4103/0973-1482.188426 – volume: 13 start-page: 1874. year: 2021 ident: R20-20240828 article-title: Liquid biopsies in head and neck cancer: Current state and future challenges publication-title: Cancers (Basel) doi: 10.3390/cancers13081874 |
| SSID | ssib044732535 ssj0002511772 ssib053799620 |
| Score | 2.24656 |
| Snippet | The treatment of oral cavity cancer primarily depends on the location, tumor size, and feasibility of organ preservation in patients with negative margins. A... |
| SourceID | crossref wolterskluwer |
| SourceType | Enrichment Source Index Database Publisher |
| StartPage | S6 |
| SubjectTerms | Special Article |
| Title | Indian clinical practice consensus guidelines for the management of oral cavity cancer: Update 2022 |
| URI | https://doi.org/10.4103/crst.crst_119_23 |
| Volume | 7 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV07T8MwELagSAgJIZ6iPCoPLAyhcWzHCVuFWhWkskBFt8hxbQZoWvUhNn47d3mUVgImFmeJE-m7k-8734uQKx67UIJh8QyokydSq71I29Tj4Ewwo6yUBguce49hty8eBnJQ3ndgLcxK_F4wnzcNcKAbXICqxknAN8lWoFiM-vvC25XmCKF4IL8Nv-QKeHxJhPBMRiKt8klOQPfh4Ak4L2KWP_5kzUbtfowxbj17y9PWV4xPZ5_slayRtgoxH5ANmx2S7V4ZFz8i5j5DOdOqzpFWxU_UYLZ0NlvM6OsCO1phljsFokqB-NHRMveFjh3FWn1qNA6TgAcow_SW9id4I0ADsMHHpN9pP991vXJ8gmdYLN_BKQxdpJUWqYyA9QTArYRjkbLG-kJJx8GTc9YNXciDWDohhZbMhkNmnFMOaMMJqWXjzJ4SGtrYaiaNESBDYaNU-077UTqMUiWcYXXSrABLTNlbHEdcvCfgYyDESY7uCsR1cr3cMSn6avzxbmtNBsmoqBT8dUPyFCYF7kmF-9k_fOOc7ADcoriAuSC1-XRhL4GSzNNG7srD2vtsN3LN_AKcNOMt |
| linkProvider | Wolters Kluwer Health |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Indian+clinical+practice+consensus+guidelines+for+the+management+of+oral+cavity+cancer%3A+Update+2022&rft.jtitle=Cancer+research%2C+statistics%2C+and+treatment+%28Online%29&rft.au=Chaturvedi%2C+Pankaj&rft.au=Prabhash%2C+Kumar&rft.au=Babu%2C+K+Govind&rft.au=Kuriakose%2C+Moni&rft.date=2024-01-01&rft.pub=Wolters+Kluwer+-+Medknow&rft.issn=2590-3233&rft.eissn=2590-3225&rft.volume=7&rft.issue=Suppl+1&rft.spage=S6&rft.epage=S11&rft_id=info:doi/10.4103%2Fcrst.crst_119_23&rft.externalDocID=CRSAT-7-S6 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2590-3233&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2590-3233&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2590-3233&client=summon |